SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-061330
Filing Date
2011-11-07
Accepted
2011-11-07 06:47:45
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a11-25767_110q.htm 10-Q 1015475
2 EX-31.1.1 a11-25767_1ex31d1d1.htm EX-31.1.1 12217
3 EX-31.2.1 a11-25767_1ex31d2d1.htm EX-31.2.1 12361
4 EX-32.1 a11-25767_1ex32d1.htm EX-32.1 6975
  Complete submission text file 0001104659-11-061330.txt   4338739

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT osir-20110930.xml EX-101.INS 730097
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT osir-20110930.xsd EX-101.SCH 16202
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT osir-20110930_cal.xml EX-101.CAL 41415
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT osir-20110930_def.xml EX-101.DEF 89063
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT osir-20110930_lab.xml EX-101.LAB 258065
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT osir-20110930_pre.xml EX-101.PRE 120944
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32966 | Film No.: 111182812
SIC: 2836 Biological Products, (No Diagnostic Substances)